253 related articles for article (PubMed ID: 34057082)
1. Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Wei W; Liu Y; Dai CL; Baazaoui N; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2021; 82(2):631-646. PubMed ID: 34057082
[TBL] [Abstract][Full Text] [Related]
2. Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice.
Wei W; Wang Y; Liu Y; Dai CL; Tung YC; Liu F; Iqbal K
Alzheimers Res Ther; 2020 Aug; 12(1):102. PubMed ID: 32854771
[TBL] [Abstract][Full Text] [Related]
3. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
[TBL] [Abstract][Full Text] [Related]
4. Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
Baazaoui N; Iqbal K
Alzheimers Res Ther; 2017 Jun; 9(1):45. PubMed ID: 28655344
[TBL] [Abstract][Full Text] [Related]
5. Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
Baazaoui N; Iqbal K
J Alzheimers Dis; 2017; 58(1):215-230. PubMed ID: 28387677
[TBL] [Abstract][Full Text] [Related]
6. Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound.
Bolognin S; Buffelli M; Puoliväli J; Iqbal K
Neurobiol Aging; 2014 Sep; 35(9):2134-46. PubMed ID: 24702821
[TBL] [Abstract][Full Text] [Related]
7. Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.
Kazim SF; Blanchard J; Bianchi R; Iqbal K
Sci Rep; 2017 Apr; 7():45561. PubMed ID: 28368015
[TBL] [Abstract][Full Text] [Related]
8. Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice.
Li B; Wanka L; Blanchard J; Liu F; Chohan MO; Iqbal K; Grundke-Iqbal I
FEBS Lett; 2010 Aug; 584(15):3359-65. PubMed ID: 20600002
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer-like behavior and synaptic dysfunction in 3 × Tg-AD mice are reversed with calcineurin inhibition.
Zeng J; Hu XF; Sun DS; Hong XY; Ma JZ; Feng Q
Exp Brain Res; 2024 Jun; 242(6):1507-1515. PubMed ID: 38719948
[TBL] [Abstract][Full Text] [Related]
10. Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Kazim SF; Iqbal K
Mol Neurodegener; 2016 Jul; 11(1):50. PubMed ID: 27400746
[TBL] [Abstract][Full Text] [Related]
11. Alterations in synaptic plasticity coincide with deficits in spatial working memory in presymptomatic 3xTg-AD mice.
Clark JK; Furgerson M; Crystal JD; Fechheimer M; Furukawa R; Wagner JJ
Neurobiol Learn Mem; 2015 Nov; 125():152-162. PubMed ID: 26385257
[TBL] [Abstract][Full Text] [Related]
12. Adiponectin Ameliorates Cognitive Behaviors and in vivo Synaptic Plasticity Impairments in 3xTg-AD Mice.
Yan XD; Qu XS; Yin J; Qiao J; Zhang J; Qi JS; Wu MN
J Alzheimers Dis; 2022; 85(1):343-357. PubMed ID: 34806605
[TBL] [Abstract][Full Text] [Related]
13. Grape Seed Proanthocyanidin Extract Ameliorates Streptozotocin-induced Cognitive and Synaptic Plasticity Deficits by Inhibiting Oxidative Stress and Preserving AKT and ERK Activities.
Gao WL; Li XH; Dun XP; Jing XK; Yang K; Li YK
Curr Med Sci; 2020 Jun; 40(3):434-443. PubMed ID: 32681248
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice.
Blanchard J; Wanka L; Tung YC; Cárdenas-Aguayo Mdel C; LaFerla FM; Iqbal K; Grundke-Iqbal I
Acta Neuropathol; 2010 Nov; 120(5):605-21. PubMed ID: 20697724
[TBL] [Abstract][Full Text] [Related]
15. Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease.
Bomba M; Granzotto A; Castelli V; Onofrj M; Lattanzio R; Cimini A; Sensi SL
J Alzheimers Dis; 2019; 70(3):793-810. PubMed ID: 31256135
[TBL] [Abstract][Full Text] [Related]
16. Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
Ibi D; Hirashima K; Kojima Y; Sumiya K; Kondo S; Yamamoto M; Ando T; Hiramatsu M
J Alzheimers Dis; 2021; 79(2):639-652. PubMed ID: 33337369
[TBL] [Abstract][Full Text] [Related]
17. High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3×Tg-AD Mouse Model.
Zhang J; Hua XF; Gu J; Chen F; Gu J; Gong CX; Liu F; Dai CL
J Alzheimers Dis; 2020; 74(3):851-864. PubMed ID: 32116254
[TBL] [Abstract][Full Text] [Related]
18. Lemon essential oil ameliorates age-associated cognitive dysfunction via modulating hippocampal synaptic density and inhibiting acetylcholinesterase.
Liu B; Kou J; Li F; Huo D; Xu J; Zhou X; Meng D; Ghulam M; Artyom B; Gao X; Ma N; Han D
Aging (Albany NY); 2020 May; 12(9):8622-8639. PubMed ID: 32392535
[TBL] [Abstract][Full Text] [Related]
19. Blockade of adenosine A
Silva AC; Lemos C; Gonçalves FQ; Pliássova AV; Machado NJ; Silva HB; Canas PM; Cunha RA; Lopes JP; Agostinho P
Neurobiol Dis; 2018 Sep; 117():72-81. PubMed ID: 29859867
[TBL] [Abstract][Full Text] [Related]
20. Huatuo Zaizao pill ameliorates cognitive impairment of APP/PS1 transgenic mice by improving synaptic plasticity and reducing Aβ deposition.
Zhang JH; Yu LJ; Yang H; Hui Z; Jiang S; Chen L; Zhao Y; Wang SL; Liu Y; Xu Y
BMC Complement Altern Med; 2018 May; 18(1):167. PubMed ID: 29843688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
